The Role of Cystine/Glutamate Antiporter SLC7A11/xCT in the Pathophysiology of Cancer
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of Cystine/Glutamate Antiporter SLC7A11/xCT in the Pathophysiology of Cancer
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-02-23
DOI
10.3389/fonc.2022.858462
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metabolism of Amino Acids in Cancer
- (2021) Zhen Wei et al. Frontiers in Cell and Developmental Biology
- Sulfasalazine, a potent suppressor of gastric cancer proliferation and metastasis by inhibition of xCT: Conventional drug in new use
- (2021) Jinfu Zhuang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Inhibiting xCT/SLC7A11 induces ferroptosis of myofibroblastic hepatic stellate cells but exacerbates chronic liver injury
- (2021) Kuo Du et al. LIVER INTERNATIONAL
- Identification of ferroptosis as a novel mechanism for antitumor activity of natural product derivative a2 in gastric cancer
- (2021) Ying Liu et al. Acta Pharmaceutica Sinica B
- A novel survival model based on a Ferroptosis-related gene signature for predicting overall survival in bladder cancer
- (2021) Yingchun Liang et al. BMC CANCER
- IL‐1β‐Induced Elevation of Solute Carrier Family 7 Member 11 Promotes Hepatocellular Carcinoma Metastasis Through Up‐regulating Programmed Death Ligand 1 and Colony‐Stimulating Factor 1
- (2021) Qin He et al. HEPATOLOGY
- SLC7A11 regulated by NRF2 modulates esophageal squamous cell carcinoma radiosensitivity by inhibiting ferroptosis
- (2021) Lei Feng et al. Journal of Translational Medicine
- Elesclomol induces copper‐dependent ferroptosis in colorectal cancer cells via degradation of ATP7A
- (2021) Wei Gao et al. Molecular Oncology
- Cystine–glutamate antiporter deletion accelerates motor recovery and improves histological outcomes following spinal cord injury in mice
- (2021) Lindsay Sprimont et al. Scientific Reports
- MiR-375 reduces the stemness of gastric cancer cells through triggering ferroptosis
- (2021) Haiwei Ni et al. Stem Cell Research & Therapy
- Lidocaine Promoted Ferroptosis by Targeting miR-382-5p /SLC7A11 Axis in Ovarian and Breast Cancer
- (2021) Dan Sun et al. Frontiers in Pharmacology
- Levobupivacaine Induces Ferroptosis by miR-489-3p/SLC7A11 Signaling in Gastric Cancer
- (2021) Shun-Hong Mao et al. Frontiers in Pharmacology
- Intra-Tumoral Expression of SLC7A11 Is Associated with Immune Microenvironment, Drug Resistance, and Prognosis in Cancers: A Pan-Cancer Analysis
- (2021) Jiajun He et al. Frontiers in Genetics
- Prognostic and Immunological Role of Key Genes of Ferroptosis in Pan-Cancer
- (2021) Zhi-Zhou Shi et al. Frontiers in Cell and Developmental Biology
- The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression
- (2020) Guang Lei et al. CELL RESEARCH
- xCT (SLC7A11) expression confers intrinsic resistance to physical plasma treatment in tumor cells
- (2020) Sander Bekeschus et al. Redox Biology
- Loss of Cardiac Ferritin H Facilitates Cardiomyopathy via Slc7a11-Mediated Ferroptosis
- (2020) Xuexian Fang et al. CIRCULATION RESEARCH
- Cystine transporter regulation of pentose phosphate pathway dependency and disulfide stress exposes a targetable metabolic vulnerability in cancer
- (2020) Xiaoguang Liu et al. NATURE CELL BIOLOGY
- IMCA Induces Ferroptosis Mediated by SLC7A11 through the AMPK/mTOR Pathway in Colorectal Cancer
- (2020) Lei Zhang et al. Oxidative Medicine and Cellular Longevity
- Cysteine depletion induces pancreatic tumor ferroptosis in mice
- (2020) Michael A. Badgley et al. SCIENCE
- MiR-139-5p/SLC7A11 inhibits the proliferation, invasion and metastasis of pancreatic carcinoma via PI3K/Akt signaling pathway
- (2020) Jin-Hui Zhu et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Tanshinone IIA induces ferroptosis in gastric cancer cells through p53 mediated-SLC7A11 down-regulation
- (2020) Zhenhua Guan et al. BIOSCIENCE REPORTS
- Targeting SLC7A11 specifically suppresses the progression of colorectal cancer stem cells via inducing ferroptosis
- (2020) Xiaotian Xu et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- xCT: A Critical Molecule That Links Cancer Metabolism to Redox Signaling
- (2020) Jinyun Liu et al. MOLECULAR THERAPY
- Nrf2 and STAT3 Alleviates Ferroptosis-Mediated IIR-ALI by Regulating SLC7A11
- (2020) Zhuanzhuan Qiang et al. Oxidative Medicine and Cellular Longevity
- Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy
- (2020) Pranavi Koppula et al. Protein & Cell
- Effective ferroptotic small-cell lung cancer cell death from SLC7A11 inhibition by sulforaphane
- (2020) Yuko Iida et al. Oncology Letters
- Metabolic Constants and Plasticity of Cancer Cells in a Limiting Glucose and Glutamine Microenvironment—A Pyruvate Perspective
- (2020) Angela M. Otto Frontiers in Oncology
- Regulation of H2A ubiquitination and SLC7A11 expression by BAP1 and PRC1
- (2019) Yilei Zhang et al. CELL CYCLE
- Sulfasalazine may modulate the CD 44v9‐ xCT system and enhance CDDP ‐induced cytotoxic effects in metastatic bladder cancer
- (2019) Koichiro Ogihara et al. CANCER SCIENCE
- Targeting the Vulnerability of Glutathione Metabolism in ARID1A-Deficient Cancers
- (2019) Hideaki Ogiwara et al. CANCER CELL
- Targeting Ferroptosis to Iron Out Cancer
- (2019) Behrouz Hassannia et al. CANCER CELL
- LKB1 and KEAP1/NRF2 pathways cooperatively promote metabolic reprogramming with enhanced glutamine dependence in KRAS-mutant lung adenocarcinoma
- (2019) Ana Galan-Cobo et al. CANCER RESEARCH
- CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy
- (2019) Weimin Wang et al. NATURE
- ALOX12 is required for p53-mediated tumour suppression through a distinct ferroptosis pathway
- (2019) Bo Chu et al. NATURE CELL BIOLOGY
- Cystine/glutamate antiporter xCT (SLC7A11) facilitates oncogenic RAS transformation by preserving intracellular redox balance
- (2019) Jonathan K. M. Lim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Quantification of microenvironmental metabolites in murine cancers reveals determinants of tumor nutrient availability
- (2019) Mark R Sullivan et al. eLife
- The Non-Essential Amino Acid Cysteine Becomes Essential for Tumor Proliferation and Survival
- (2019) Joseph A. Combs et al. Cancers
- Ambidextrous Approach To Disrupt Redox Balance in Tumor Cells with Increased ROS Production and Decreased GSH Synthesis for Cancer Therapy
- (2019) Longfa Kou et al. ACS Applied Materials & Interfaces
- Genetic Ablation of the Cystine Transporter xCT in PDAC Cells Inhibits mTORC1, Growth, Survival, and Tumor Formation via Nutrient and Oxidative Stresses
- (2019) Boutaina Daher et al. CANCER RESEARCH
- Radiotherapy and immunotherapy promote tumoral lipid oxidation and ferroptosis via synergistic repression of SLC7A11
- (2019) Xueting Lang et al. Cancer Discovery
- Dosing Time-Dependent Changes in the Anti-tumor Effect of xCT Inhibitor Erastin in Human Breast Cancer Xenograft Mice
- (2019) Shoya Shiromizu et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Transsulfuration Activity Can Support Cell Growth upon Extracellular Cysteine Limitation
- (2019) Jiajun Zhu et al. Cell Metabolism
- Low-Concentration PTX And RSL3 Inhibits Tumor Cell Growth Synergistically By Inducing Ferroptosis In Mutant p53 Hypopharyngeal Squamous Carcinoma
- (2019) Jing Ye et al. Cancer Management and Research
- Suppression of the SLC7A11/glutathione axis causes synthetic lethality in KRAS-mutant lung adenocarcinoma
- (2019) Kewen Hu et al. JOURNAL OF CLINICAL INVESTIGATION
- NRF2 and the Hallmarks of Cancer
- (2018) Montserrat Rojo de la Vega et al. CANCER CELL
- High expression of CD44v9 and xCT in chemoresistant hepatocellular carcinoma: potential targets by sulfasalazine
- (2018) Fumitaka Wada et al. CANCER SCIENCE
- An Acquired Vulnerability of Drug-Resistant Melanoma with Therapeutic Potential
- (2018) Liqin Wang et al. CELL
- Extracellular redox state shift: A novel approach to target prostate cancer invasion
- (2018) Weixiong Zhong et al. FREE RADICAL BIOLOGY AND MEDICINE
- Overexpression of SLC7A11: a novel oncogene and an indicator of unfavorable prognosis for liver carcinoma
- (2018) Liang Zhang et al. Future Oncology
- A novel scoring system for acute myeloid leukemia risk assessment based on the expression levels of six genes
- (2018) Xiaoyan Zhao et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- TRAP-seq identifies cystine/glutamate antiporter as a driver of recovery from liver injury
- (2018) Amber W. Wang et al. JOURNAL OF CLINICAL INVESTIGATION
- xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression
- (2018) Xiangming Ji et al. ONCOGENE
- Glucose metabolism and NRF2 coordinate the antioxidant response in melanoma resistant to MAPK inhibitors
- (2018) Raeeka Khamari et al. Cell Death & Disease
- BAP1 links metabolic regulation of ferroptosis to tumour suppression
- (2018) Yilei Zhang et al. NATURE CELL BIOLOGY
- Amino acid transporters revisited: New views in health and disease
- (2018) Palanivel Kandasamy et al. TRENDS IN BIOCHEMICAL SCIENCES
- Bovine herpesvirus 4-based vector delivering the full length xCT DNA efficiently protects mice from mammary cancer metastases by targeting cancer stem cells
- (2018) Gaetano Donofrio et al. OncoImmunology
- Activated Integrated Stress Response Induced by Salubrinal Promotes Cisplatin Resistance in Human Gastric Cancer Cells via Enhanced xCT Expression and Glutathione Biosynthesis
- (2018) Sheng-Fan Wang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Microarray-based identification of genes associated with prognosis and drug resistance in ovarian cancer
- (2018) Fuqiang Yin et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Upregulation of the solute carrier family 7 genes is indicative of poor prognosis in papillary thyroid carcinoma
- (2018) Lei Shen et al. World Journal of Surgical Oncology
- Participation of xCT in melanoma cell proliferation in vitro and tumorigenesis in vivo
- (2018) Seung-Shick Shin et al. Oncogenesis
- The glutamate/cystine antiporter SLC7A11/xCT enhances cancer cell dependency on glucose by exporting glutamate
- (2017) Pranavi Koppula et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- mTORC2 Regulates Amino Acid Metabolism in Cancer by Phosphorylation of the Cystine-Glutamate Antiporter xCT
- (2017) Yuchao Gu et al. MOLECULAR CELL
- Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis
- (2017) Rodrigo Romero et al. NATURE MEDICINE
- ATF4 promotes angiogenesis and neuronal cell death and confers ferroptosis in a xCT-dependent manner
- (2017) D Chen et al. ONCOGENE
- ROS in Cancer: The Burning Question
- (2017) Iok In Christine Chio et al. TRENDS IN MOLECULAR MEDICINE
- The glutamate/cystine xCT antiporter antagonizes glutamine metabolism and reduces nutrient flexibility
- (2017) Chun-Shik Shin et al. Nature Communications
- Decreased expression of the long non-coding RNA SLC7A11-AS1 predicts poor prognosis and promotes tumor growth in gastric cancer
- (2017) Yajun Luo et al. Oncotarget
- Environmental cystine drives glutamine anaplerosis and sensitizes cancer cells to glutaminase inhibition
- (2017) Alexander Muir et al. eLife
- MiR-375/SLC7A11 axis regulates oral squamous cell carcinoma proliferation and invasion
- (2017) Yadong Wu et al. Cancer Medicine
- Recent developments in the role of reactive oxygen species in allergic asthma
- (2017) Jingjing Qu et al. Journal of Thoracic Disease
- Identification of capsazepine as a novel inhibitor of system xc− and cancer-induced bone pain
- (2017) Jennifer Fazzari et al. Journal of Pain Research
- A Virus-Like-Particle immunotherapy targeting Epitope-Specific anti-xCT expressed on cancer stem cell inhibits the progression of metastatic cancer in vivo
- (2017) Elisabetta Bolli et al. OncoImmunology
- Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer
- (2016) Jong-Lyel Roh et al. CANCER LETTERS
- The EGF Receptor Promotes the Malignant Potential of Glioma by Regulating Amino Acid Transport System xc(--)
- (2016) K. Tsuchihashi et al. CANCER RESEARCH
- The Emerging Hallmarks of Cancer Metabolism
- (2016) Natalya N. Pavlova et al. Cell Metabolism
- The integrated stress response
- (2016) Karolina Pakos‐Zebrucka et al. EMBO REPORTS
- An African-specific polymorphism in theTP53gene impairs p53 tumor suppressor function in a mouse model
- (2016) Matthew Jennis et al. GENES & DEVELOPMENT
- Increased Expression of System x c − in Glioblastoma Confers an Altered Metabolic State and Temozolomide Resistance
- (2016) Monika D. Polewski et al. MOLECULAR CANCER RESEARCH
- Redox Regulation of Stem-like Cells Though the CD44v-xCT Axis in Colorectal Cancer: Mechanisms and Therapeutic Implications
- (2016) Huai-Qiang Ju et al. Theranostics
- Immunotargeting of Antigen xCT Attenuates Stem-like Cell Behavior and Metastatic Progression in Breast Cancer
- (2015) S. Lanzardo et al. CANCER RESEARCH
- Ferroptosis as a p53-mediated activity during tumour suppression
- (2015) Le Jiang et al. NATURE
- Metabolic pathways promoting cancer cell survival and growth
- (2015) Lindsey K. Boroughs et al. NATURE CELL BIOLOGY
- SLC7A11 expression is associated with seizures and predicts poor survival in patients with malignant glioma
- (2015) Stephanie M. Robert et al. Science Translational Medicine
- Mammalian SWI/SNF chromatin remodeling complexes and cancer: Mechanistic insights gained from human genomics
- (2015) C. Kadoch et al. Science Advances
- Behavioral characterization of system xc- mutant mice
- (2014) Elizabeth A. McCullagh et al. BEHAVIOURAL BRAIN RESEARCH
- Reduced Expression of miRNA-27a Modulates Cisplatin Resistance in Bladder Cancer by Targeting the Cystine/Glutamate Exchanger SLC7A11
- (2014) R. M. Drayton et al. CLINICAL CANCER RESEARCH
- Pharmacological inhibition of cystine–glutamate exchange induces endoplasmic reticulum stress and ferroptosis
- (2014) Scott J Dixon et al. eLife
- Glutamine Sensitivity Analysis Identifies the xCT Antiporter as a Common Triple-Negative Breast Tumor Therapeutic Target
- (2013) Luika A. Timmerman et al. CANCER CELL
- Iron-dependent cell death of hepatocellular carcinoma cells exposed to sorafenib
- (2013) Christophe Louandre et al. INTERNATIONAL JOURNAL OF CANCER
- Glutamine and cancer: cell biology, physiology, and clinical opportunities
- (2013) Christopher T. Hensley et al. JOURNAL OF CLINICAL INVESTIGATION
- Emerging roles for chromatin as a signal integration and storage platform
- (2013) Aimee I. Badeaux et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The Cystine/Glutamate Antiporter System xc− in Health and Disease: From Molecular Mechanisms to Novel Therapeutic Opportunities
- (2012) Jan Lewerenz et al. ANTIOXIDANTS & REDOX SIGNALING
- Tumor Suppression in the Absence of p53-Mediated Cell-Cycle Arrest, Apoptosis, and Senescence
- (2012) Tongyuan Li et al. CELL
- Alternative splicing of CD44 mRNA by ESRP1 enhances lung colonization of metastatic cancer cell
- (2012) Toshifumi Yae et al. Nature Communications
- The oxidative stress-inducible cystine/glutamate antiporter, system x c − : cystine supplier and beyond
- (2011) Marcus Conrad et al. AMINO ACIDS
- CD44 Variant Regulates Redox Status in Cancer Cells by Stabilizing the xCT Subunit of System xc− and Thereby Promotes Tumor Growth
- (2011) Takatsugu Ishimoto et al. CANCER CELL
- Disruption of xCT inhibits cell growth via the ROS/autophagy pathway in hepatocellular carcinoma
- (2011) Weijie Guo et al. CANCER LETTERS
- MicroRNA-26b is underexpressed in human breast cancer and induces cell apoptosis by targeting SLC7A11
- (2011) Xiao-Xiao Liu et al. FEBS LETTERS
- Loss of System xFormula Does Not Induce Oxidative Stress But Decreases Extracellular Glutamate in Hippocampus and Influences Spatial Working Memory and Limbic Seizure Susceptibility
- (2011) D. De Bundel et al. JOURNAL OF NEUROSCIENCE
- The therapeutic promise of the cancer stem cell concept
- (2010) Natasha Y. Frank et al. JOURNAL OF CLINICAL INVESTIGATION
- Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB
- (2010) Johanna C. Scheuermann et al. NATURE
- Early termination of ISRCTN45828668, a phase 1/2 prospective, randomized study of Sulfasalazine for the treatment of progressing malignant gliomas in adults
- (2009) Pierre A Robe et al. BMC CANCER
- Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
- (2009) Dunyaporn Trachootham et al. NATURE REVIEWS DRUG DISCOVERY
- Oxygen Toxicity and Reactive Oxygen Species: The Devil Is in the Details
- (2009) Richard L Auten et al. PEDIATRIC RESEARCH
- Extracellular thiol-assisted selenium uptake dependent on the xc- cystine transporter explains the cancer-specific cytotoxicity of selenite
- (2009) E. Olm et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- ATF4-dependent transcription mediates signaling of amino acid limitation
- (2009) Michael S. Kilberg et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- JNK activation mediates the apoptosis of xCT-deficient cells
- (2008) Hai-Xuan Qiao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The xc− cystine/glutamate antiporter: a mediator of pancreatic cancer growth with a role in drug resistance
- (2008) M Lo et al. BRITISH JOURNAL OF CANCER
- Regulation of glutathione synthesis
- (2008) Shelly C. Lu MOLECULAR ASPECTS OF MEDICINE
- Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
- (2008) Scott M. Wilhelm et al. MOLECULAR CANCER THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now